Literature DB >> 7907301

Transgenic animals in toxicology.

T L Goldsworthy1, L Recio, K Brown, L A Donehower, J C Mirsalis, R W Tennant, I F Purchase.   

Abstract

Recent advances have been made in the characterization of a number of transgenic animal models. These animal models have provided a powerful toxicological tool for studying in vivo chemical effects and have increased our understanding of the role of specific genetic alterations as predisposing factors for chemical carcinogenesis. The goal of this symposium was to introduce the development of transgenic animals and the utilization of transgenics in toxicology research focusing on understanding tissue-specific mutation, chemical effects, and cancer. The production of transgenic animals, including gene insertions and gene knockouts, and the utilization of transgenic technology for studying multistage carcinogenesis and tumor suppressor genes are described. Data on the application and implications of transgenics as a genetic endpoint are also discussed. The use of transgenic animals in toxicology should improve our understanding of the role of specific genetic alterations in the carcinogenic process and lead to improved estimations of human health risks.

Entities:  

Mesh:

Year:  1994        PMID: 7907301     DOI: 10.1006/faat.1994.1002

Source DB:  PubMed          Journal:  Fundam Appl Toxicol        ISSN: 0272-0590


  9 in total

Review 1.  Evaluation of the carcinogenic potential of pharmaceuticals. Opportunities arising from the International Conference on Harmonisation.

Authors:  A M Monro; J S MacDonald
Journal:  Drug Saf       Date:  1998-05       Impact factor: 5.606

2.  p16INK4a reporter mice reveal age-promoting effects of environmental toxicants.

Authors:  Jessica A Sorrentino; Janakiraman Krishnamurthy; Stephen Tilley; James G Alb; Christin E Burd; Norman E Sharpless
Journal:  J Clin Invest       Date:  2013-12-16       Impact factor: 14.808

Review 3.  The use of genetically modified mice in cancer risk assessment: challenges and limitations.

Authors:  David A Eastmond; Suryanarayana V Vulimiri; John E French; Babasaheb Sonawane
Journal:  Crit Rev Toxicol       Date:  2013-09       Impact factor: 5.635

Review 4.  Topics in cancer risk assessment.

Authors:  S S Olin; D A Neumann; J A Foran; G J Scarano
Journal:  Environ Health Perspect       Date:  1997-02       Impact factor: 9.031

Review 5.  Molecular epidemiology in environmental health: the potential of tumor suppressor gene p53 as a biomarker.

Authors:  J C Semenza; L H Weasel
Journal:  Environ Health Perspect       Date:  1997-02       Impact factor: 9.031

Review 6.  Occupational cancer in France: epidemiology, toxicology, prevention, and compensation.

Authors:  J C Aubrun; S Binet; C Bozec; P Brochard; S Dimerman; B Fontaine; P Guénel; D Luce; Y Martinet; J J Moulin; J M Mur; M Pietruszynski; C Vallayer
Journal:  Environ Health Perspect       Date:  1999-05       Impact factor: 9.031

Review 7.  In vivo transgenic bioassays and assessment of the carcinogenic potential of pharmaceuticals.

Authors:  J F Contrera; J J DeGeorge
Journal:  Environ Health Perspect       Date:  1998-02       Impact factor: 9.031

Review 8.  Assessing the potential carcinogenic activity of magnetic fields using animal models.

Authors:  J McCann; R Kavet; C N Rafferty
Journal:  Environ Health Perspect       Date:  2000-03       Impact factor: 9.031

Review 9.  Anomalous nonidentity between Salmonella genotoxicants and rodent carcinogens: nongenotoxic carcinogens and genotoxic noncarcinogens.

Authors:  K Yoshikawa
Journal:  Environ Health Perspect       Date:  1996-01       Impact factor: 9.031

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.